GB
Publications
70
Views
18,336
Downloads
5,091
Supervised works
0
Items per page
1 - 70 of 70
Title Published in Access level OA Policy Year Views Downloads
Reply to Hinpetch DaungsupawongPediatric allergy and immunology
accessLevelRestricted
2025 10 0
Vaccine immunity in patients with 22q11.2 microdeletion syndromePediatric allergy and immunology
accessLevelRestricted
2025 48 2
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins : 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trialEClinicalMedicine
accessLevelPublic
2024 43 32
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infectionPediatric allergy and immunology
accessLevelPublic
2024 94 82
Vaccine immunity in children after hematologic cancer treatment : a retrospective single-center studyJournal of pediatric hematology/oncology
accessLevelPublic
2024 34 23
One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19The Pediatric infectious disease journal
accessLevelPublic
2024 38 54
Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients : A nationwide retrospective studyAmerican journal of transplantation
accessLevelPublic
2024 66 26
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenScience
accessLevelPublic
2023 49 13
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
accessLevelPublic
2023 60 66
Utilité clinique des genome boards pour les maladies génétiques complexesRevue médicale suisse
accessLevelPublic
2023 146 37
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 175 32
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic diseaseThe journal of experimental medicine
accessLevelPublic
2023 38 11
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) : an open-label, multicentre, randomised trialThe Lancet. Child & adolescent health
accessLevelPublic
2023 34 24
Hyper-IgE syndrome presenting with early life craniosynostosis in monozygotic twin sistersPediatric allergy and immunology
accessLevelPublic
2023 92 46
Autoantibodies to a nodal isoform of neurofascin in pediatric chronic inflammatory demyelinating polyneuropathyChild neurology open
accessLevelPublic
2023 17 23
Quelles pathologies immunologiques sont ciblées par la médecine de précision ?Revue médicale suisse
accessLevelPublic
2023 27 9
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19Genome medicine
accessLevelPublic
2023 42 11
Vaccination of immunosuppressed children in clinical practice
accessLevelRestricted
2022 36 0
Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19Journal of molecular medicine
accessLevelPublic
2022 60 29
Acceptability of COVID-19 Vaccine Among Hospital Employees in the Department of Paediatrics, Gynaecology and Obstetrics in the University Hospitals of Geneva, SwitzerlandFrontiers in public health
accessLevelPublic
2022 88 63
Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant FormsFrontiers in immunology
accessLevelPublic
2022 256 106
Novel approaches to reactivate pertussis immunityExpert review of vaccines
accessLevelPublic
2022 140 168
Evaluation of rotavirus vaccine administration among a 22q11.2DS patient populationAllergy, asthma, and clinical immunology
accessLevelPublic
2022 120 67
Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome — Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY TrialFrontiers in pediatrics
accessLevelPublic
2022 186 54
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 172 122
Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical GuideFrontiers in immunology
accessLevelPublic
2021 262 127
Maladies infectieusesRevue médicale suisse
accessLevelPublic
2021 357 92
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in SwitzerlandFrontiers in pediatrics
accessLevelPublic
2021 65 36
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 390 209
Meningitis Caused by the Live Varicella Vaccine Virus: Metagenomic Next Generation Sequencing, Immunology Exome Sequencing and Cytokine Multiplex ProfilingViruses
accessLevelPublic
2021 188 135
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 270 102
X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children - A Case ReportFrontiers in pediatrics
accessLevelPublic
2021 71 41
Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19Journal of the Pediatric Infectious Diseases Society
accessLevelPublic
2021 295 42
Case report: case series of children with multisystem inflammatory syndrome following SARS-CoV-2 infection in SwitzerlandFrontiers in pediatrics
accessLevelPublic
2021 160 97
Pediatric Acute B-Cell Lymphoblastic Leukemia Developing Following Recent SARS-CoV-2 InfectionJournal of pediatric hematology/oncology
accessLevelRestricted
2021 219 0
Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCTFrontiers in immunology
accessLevelPublic
2021 238 104
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipientsVaccine
accessLevelRestricted
2021 193 0
Pediatric COVID-19: Immunopathogenesis, Transmission and PreventionVaccines
accessLevelPublic
2021 201 72
Vaccination in immunosuppressed children: a comprehensive review and practical guide
accessLevelRestricted
2020 413 4
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialClinical Microbiology and Infection
accessLevelPublic
2020 274 133
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19)Clinical Infectious Diseases
accessLevelPublic
2020 446 281
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 491 185
Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysisInfluenza and other Respiratory Viruses
accessLevelPublic
2019 248 139
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidatesAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
accessLevelRestricted
2019 403 3
Germline CBM-opathies: From immunodeficiency to atopyJournal of Allergy and Clinical Immunology
accessLevelRestricted
2019 220 0
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical TrialClinical Infectious Diseases
accessLevelPublic
2019 281 286
A 19-month-old boy with refractory cervical adenitisPediatric Infectious Disease Journal
accessLevelRestricted
2019 357 1
Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking LymphomaJournal of Pediatric Hematology / Oncology
accessLevelRestricted
2018 461 1
Review of maternal immunisation during pregnancy: focus on pertussis and influenzaSwiss Medical Weekly
accessLevelPublic
2017 329 131
Parler vaccination aux parents : un défi pour le médecin de premier recoursRevue médicale suisse
accessLevelPublic
2017 339 104
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
accessLevelPublic
2017 597 232
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
accessLevelRestricted
2016 706 5
Impact de la vaccination sur les otites moyennes aiguësRevue médicale suisse
accessLevelRestricted
2016 402 1
Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional StudyInternational journal of environmental research and public health
accessLevelPublic
2015 670 279
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdomClinical and vaccine immunology
accessLevelRestricted
2014 544 0
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United KingdomPediatric Infectious Disease Journal
accessLevelRestricted
2013 148 0
The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of ageVaccine
accessLevelPublic
2013 401 195
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newbornThe Pediatric infectious disease journal
accessLevelRestricted
2013 701 3
Acceptability of maternal immunization against influenza: the critical role of obstetriciansJournal of maternal-fetal & neonatal medicine
accessLevelRestricted
2012 701 0
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionalsRevue d'épidémiologie et de santé publique
accessLevelRestricted
2012 697 3
Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccineVaccine
accessLevelPublic
2012 190 181
Vaccination during pregnancy to protect infants against influenza: why and why not?Vaccine
accessLevelRestricted
2011 589 0
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancyExpert Review of Vaccines
accessLevelRestricted
2011 157 0
Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in childrenJournal of Immunological Methods
accessLevelRestricted
2010 150 0
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccineImmunology
accessLevelPublic
2009 150 140
Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humansBlood
accessLevelPublic
2009 201 183
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseThe Journal of immunology
accessLevelRestricted
2008 580 2
Sustaining immunity after immunization against encapsulated bacteriaHuman Vaccines
accessLevelRestricted
2008 167 0
Persistence of protection against invasive bacteria-memory b cell response in infants after immunisation
accessLevelRestricted
2008 315 1
Une étude de la réponse des cellules B mémoires au vaccin polysaccharidique conjugué contre le méningocoque du sérogroupe C
accessLevelPublic
2006 1,028 441
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack